An RBD virus-like particle vaccine for SARS-CoV-2 induces cross-variant antibody responses in mice and macaques

被引：0
|
作者：
Yuanyuan Li
Yanan Zhang
Yu Zhou
Yan Li
Jiao Xu
Yuanbao Ai
Lei Xu
Xiuli Xiao
Bo Zhang
Jing Jin
机构：
[1] Patronus Biotech Co. Ltd.,Key Laboratory of Special Pathogens and Biosafety
[2] Wuhan Institute of Virology,undefined
[3] Center for Biosafety Mega-Science,undefined
[4] Chinese Academy of Sciences,undefined
来源：
Signal Transduction and Targeted Therapy | / 8卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Characteristics of epitope dominance pattern and cross-variant neutralisation in 16 SARS-CoV-2 mRNA vaccine sera
    Yasugi, Mayo
    Nakagama, Yu
    Kaku, Natsuko
    Nitahara, Yuko
    Hatanaka, Noritoshi
    Yamasaki, Shinji
    Kido, Yasutoshi
    VACCINE, 2023, 41 (42) : 6248 - 6254
  • [22] A Vaccine of SARS-CoV-2 S Protein RBD Induces Protective Immunity
    Qu, Qiaoqiao
    Hao, Pengfei
    Xu, Wang
    Li, Letian
    Jiang, Yuhang
    Xu, Zhiqiang
    Chen, Jing
    Gao, Zihan
    Pang, Zhaoxia
    Jin, Ningyi
    Li, Chang
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (22)
  • [23] Optimization and validation of a virus-like particle pseudotyped virus neutralization assay for SARS-CoV-2
    Liu, Shuo
    Zhang, Li
    Fu, Wangjun
    Liang, Ziteng
    Yu, Yuanling
    Li, Tao
    Tong, Jincheng
    Liu, Fan
    Nie, Jianhui
    Lu, Qiong
    Lu, Shuaiyao
    Huang, Weijin
    Wang, Youchun
    MEDCOMM, 2024, 5 (06):
  • [24] Cross-variant proof predictive vaccine design based on SARS-CoV-2 spike protein using immunoinformatics approach
    Sahu, Lavanya Kumar
    Singh, Kiran
    BENI-SUEF UNIVERSITY JOURNAL OF BASIC AND APPLIED SCIENCES, 2023, 12 (01)
  • [25] Limited cross-variant immunity from SARS-CoV-2 Omicron without vaccination
    Rahul K. Suryawanshi
    Irene P. Chen
    Tongcui Ma
    Abdullah M. Syed
    Noah Brazer
    Prachi Saldhi
    Camille R. Simoneau
    Alison Ciling
    Mir M. Khalid
    Bharath Sreekumar
    Pei-Yi Chen
    G. Renuka Kumar
    Mauricio Montano
    Ronne Gascon
    Chia-Lin Tsou
    Miguel A. Garcia-Knight
    Alicia Sotomayor-Gonzalez
    Venice Servellita
    Amelia Gliwa
    Jenny Nguyen
    Ines Silva
    Bilal Milbes
    Noah Kojima
    Victoria Hess
    Maria Shacreaw
    Lauren Lopez
    Matthew Brobeck
    Fred Turner
    Frank W. Soveg
    Ashley F. George
    Xiaohui Fang
    Mazharul Maishan
    Michael Matthay
    Mary Kate Morris
    Debra Wadford
    Carl Hanson
    Warner C. Greene
    Raul Andino
    Lee Spraggon
    Nadia R. Roan
    Charles Y. Chiu
    Jennifer A. Doudna
    Melanie Ott
    Nature, 2022, 607 : 351 - 355
  • [26] Beta Spike-Presenting SARS-CoV-2 Virus-like Particle Vaccine Confers Broad Protection against Other VOCs in Mice
    Ullah, Irfan
    Symmes, Kelly
    Keita, Kadiatou
    Zhu, Li
    Grunst, Michael W.
    Li, Wenwei
    Mothes, Walther
    Kumar, Priti
    Uchil, Pradeep D.
    VACCINES, 2024, 12 (09)
  • [27] A COVID-19 mRNA vaccine encoding SARS-CoV-2 virus-like particles induces a strong antiviral-like immune response in mice
    Jing Lu
    Guoliang Lu
    Shudan Tan
    Jia Xia
    Hualong Xiong
    Xiaofei Yu
    Qingqing Qi
    Xiang Yu
    Li Li
    Hang Yu
    Ningshao Xia
    Tianying Zhang
    Yingjie Xu
    Jinzhong Lin
    Cell Research, 2020, 30 : 936 - 939
  • [28] Protection of K18-hACE2 Mice against SARS-CoV-2 Challenge by a Capsid Virus-like Particle-Based Vaccine
    Myeni, Sebenzile K.
    Leijs, Anouk A.
    Bredenbeek, Peter J.
    Morales, Shessy Torres
    Linger, Marissa E.
    Fougeroux, Cyrielle
    van Zanen-Gerhardt, Sophie
    Zander, Serge A. L.
    Sander, Adam F.
    Kikkert, Marjolein
    VACCINES, 2024, 12 (07)
  • [29] A COVID-19 mRNA vaccine encoding SARS-CoV-2 virus-like particles induces a strong antiviral-like immune response in mice
    Lu, Jing
    Lu, Guoliang
    Tan, Shudan
    Xia, Jia
    Xiong, Hualong
    Yu, Xiaofei
    Qi, Qingqing
    Yu, Xiang
    Li, Li
    Yu, Hang
    Xia, Ningshao
    Zhang, Tianying
    Xu, Yingjie
    Lin, Jinzhong
    CELL RESEARCH, 2020, 30 (10) : 936 - 939
  • [30] Cross-Variant Neutralizing Serum Activity after SARS-CoV-2 Breakthrough Infections
    Tober-Lau, Pinkus
    Gruell, Henning
    Vanshylla, Kanika
    Koch, Willi M.
    Hillus, David
    Schommers, Philipp
    Suarez, Isabelle
    Suttorp, Norbert
    Sander, Leif Erik
    Klein, Florian
    Kurth, Florian
    EMERGING INFECTIOUS DISEASES, 2022, 28 (05) : 1050 - 1052
12345